B7-H3 and B7-H1 expression in cerebral spinal fluid and tumor tissue correlates with the malignancy grade of glioma patients

被引:61
作者
Baral, Aparajita [1 ,2 ]
Ye, Hong Xing [2 ]
Jiang, Pu Cha [1 ]
Yao, Yu [2 ]
Mao, Ying [2 ,3 ]
机构
[1] Wuhan Univ, Zhongnan Hosp, Dept Neurosurg, Wuhan 430071, Hubei, Peoples R China
[2] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200040, Peoples R China
[3] Fudan Univ, State Key Lab Med Neurobiol, Inst Biomed Sci, Shanghai 200032, Peoples R China
基金
美国国家科学基金会;
关键词
glioma; B7; family; B7-H3; B7-H1; cerebral spinal fluid; blood serum; COSTIMULATORY MOLECULE B7-H3; HUMAN PANCREATIC-CANCER; T-CELL ACTIVATION; CARCINOMA; MELANOMA; SURVIVAL; PROGNOSIS; RESPONSES; THERAPY; ANTIGEN;
D O I
10.3892/ol.2014.2268
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
The B7 family consists of activating and inhibitory molecules that regulate immune responses. Recent research demonstrated the roles of soluble B7-H3 (sB7-H3) and soluble B7-H1 (sB7-H1) in the blood serum of various tumors; however, none of these studies investigated the expression of these proteins in the cerebral spinal fluid (CSF) and blood serum of patients with glioma. The aim of the present study was to investigate the expression of B7-H3 and B7-H1 in the CSF, blood serum and tissues of patients with glioma and their correlation with clinicopathological data. Between January 2012 and November 2012, samples were obtained from 78 patients with glioma, four CSF samples were obtained from patients with a moderate traumatic brain injury, four brain tissue samples were obtained from patients with a traumatic brain injury and 40 blood serum samples were obtained from healthy individuals. The expression of B7-H3 and B7-H1 in the CSF, blood serum and tumor samples of the patients with high-grade glioma was found to be higher than that in the patients with low-grade glioma. However, no significant differences in sB7-H3 and sB7-H1 expression were observed in the blood serum of the patients with glioma compared with the healthy control subjects. In addition, the expression of sB7-H3 and sB7-H1 in the CSF of the patients with glioma was higher than that in the CSF of the patients with a moderate traumatic brain injury. Furthermore, in the patients with glioma, B7-H3 and B7-H1 expression in the CSF and tumor tissue, although not in the blood serum, correlated with the glioma grade.
引用
收藏
页码:1195 / 1201
页数:7
相关论文
共 28 条
[1]
T-cell coregulatory molecule expression in urothelial cell carcinoma: Clinicopathologic correlations and association with survival [J].
Boorjian, Stephen A. ;
Sheinin, Yuri ;
Crispen, Paul L. ;
Farmer, Sara A. ;
Lohse, Christine M. ;
Kuntz, Susan M. ;
Leibovich, Bradley C. ;
Kwon, Eugene D. ;
Frank, Igor .
CLINICAL CANCER RESEARCH, 2008, 14 (15) :4800-4808
[2]
B7-H3:: A costimulatory molecule for T cell activation and IFN-γ production [J].
Chapoval, AI ;
Ni, J ;
Lau, JS ;
Wilcox, RA ;
Flies, DB ;
Liu, D ;
Dong, HD ;
Sica, GL ;
Zhu, GF ;
Tamada, K ;
Chen, LP .
NATURE IMMUNOLOGY, 2001, 2 (03) :269-274
[3]
Circulating B7-H3(CD276) Elevations in Cerebrospinal Fluid and Plasma of Children with Bacterial Meningitis [J].
Chen, Xuqin ;
Zhang, Guangbo ;
li, Yan ;
Feng, Xing ;
Wan, Fengguo ;
Zhang, Liya ;
Wang, Jian ;
Zhang, Xueguang .
JOURNAL OF MOLECULAR NEUROSCIENCE, 2009, 37 (01) :86-94
[4]
The immunoregulatory protein human B7H3 is a tumor-associated antigen that regulates tumor cell migration and invasion [J].
Chen, Yih-Wen ;
Tekle, Christina ;
Fodstad, Oystein .
CURRENT CANCER DRUG TARGETS, 2008, 8 (05) :404-413
[5]
Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730
[6]
Identification of a Soluble Form of B7-H1 That Retains Immunosuppressive Activity and Is Associated with Aggressive Renal Cell Carcinoma [J].
Frigola, Xavier ;
Inman, Brant A. ;
Lohse, Christine M. ;
Krco, Christopher J. ;
Cheville, John C. ;
Thompson, R. Houston ;
Leibovich, Bradley ;
Blute, Michael L. ;
Dong, Haidong ;
Kwon, Eugene D. .
CLINICAL CANCER RESEARCH, 2011, 17 (07) :1915-1923
[7]
B7-H1 up-regulated expression in human pancreatic carcinoma tissue associates with tumor progression [J].
Geng, Lei ;
Huang, Dongsheng ;
Liu, Junwei ;
Qian, Yigang ;
Deng, Junfang ;
Li, Donglin ;
Hu, Zhenhua ;
Zhang, Jian ;
Jiang, Guoping ;
Zheng, Shusen .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2008, 134 (09) :1021-1027
[8]
Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses [J].
Hashiguchi, Masaaki ;
Kobori, Hiroko ;
Ritprajak, Patcharee ;
Kamimura, Yosuke ;
Kozono, Haruo ;
Azuma, Miyuki .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (30) :10495-10500
[9]
PD-L2 is a second ligand for PD-I and inhibits T cell activation [J].
Latchman, Y ;
Wood, CR ;
Chernova, T ;
Chaudhary, D ;
Borde, M ;
Chernova, I ;
Iwai, Y ;
Long, AJ ;
Brown, JA ;
Nunes, R ;
Greenfield, EA ;
Bourque, K ;
Boussiotis, VA ;
Carter, LL ;
Carreno, BM ;
Malenkovich, N ;
Nishimura, H ;
Okazaki, T ;
Honjo, T ;
Sharpe, AH ;
Freeman, GJ .
NATURE IMMUNOLOGY, 2001, 2 (03) :261-268
[10]
Costimulatory Protein 4IgB7H3 Drives the Malignant Phenotype of Glioblastoma by Mediating Immune Escape and Invasiveness [J].
Lemke, Dieter ;
Pfenning, Philipp-Niclas ;
Sahm, Felix ;
Klein, Ann-Catherine ;
Kempf, Tore ;
Warnken, Uwe ;
Schnoelzer, Martina ;
Tudoran, Ruxandra ;
Weller, Michael ;
Platten, Michael ;
Wick, Wolfgang .
CLINICAL CANCER RESEARCH, 2012, 18 (01) :105-117